Skip to content

Urine Output Response to Fluid and Diuretic Therapy in Cardiac ICU Patients Monitored With FIZE kUO®

FIZE kUO® Real-Time Measurement of Urine Output Response to Fluid Therapy and Diuretics in Cardiovascular Surgery Patients: A Prospective Post-Market Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07022314
Enrollment
45
Registered
2025-06-15
Start date
2026-01-01
Completion date
2027-06-01
Last updated
2026-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AKI - Acute Kidney Injury, Cardiac Surgery, Fluid Therapy, Hemodynamic Instability, Postoperative Complications

Keywords

FIZE kUO, Urine Output, Fluid Management, Diuretics, Cardiothoracic Surgery

Brief summary

This prospective observational study evaluates the real-time urine output response to fluid therapy and diuretics in cardiothoracic intensive care unit (CTICU) patients monitored with the FIZE kUO® device. The study aims to assess how continuous urine output monitoring can inform fluid management and improve patient outcomes post-cardiac surgery.

Detailed description

The study involves adult patients undergoing coronary artery bypass graft (CABG) or valve replacement/repair surgeries. Utilizing the FIZE kUO® device, continuous urine output data will be collected to analyze responses to hemodynamic interventions, including fluid boluses and diuretics. Secondary objectives include assessing urine output differences in patients with and without postoperative acute kidney injury (AKI), responses to vasopressors, and capturing real-time urine output data from FIZE kUO® for observational analysis.

Interventions

DEVICEFIZE kUO®

FIZE kUO® is a commercially available, non-invasive device used for continuous, minute-by-minute real-time urine output monitoring in patients with an indwelling Foley catheter. In this observational study, the device is used during and after cardiac surgery as part of routine clinical care. Urine output data, along with additional clinical parameters, are collected throughout the study for research analysis.

Sponsors

FIZE Medical ltd
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults aged 18 years and older scheduled for CABG or valve surgery and expected postoperative admission to CTICU 2. Ability to provide informed consent

Exclusion criteria

1. Pregnancy 2. Preoperative dialysis (chronic or acute) 3. Enrollment in other interventional trials assessing urine output or AKI

Design outcomes

Primary

MeasureTime frameDescription
Urine output response to fluid boluses and diuretics4 hours (2 hours before and 2 hours after intervention)Change in urine output measured by FIZE kUO® during 2 hours before and after fluid or diuretic administration.

Secondary

MeasureTime frameDescription
Difference in urine output during surgery between patients with and without AKIPerioperative/PeriproceduralComparison of urine output measured by FIZE kUO® in patients who develop AKI vs. those who do not
Urine output response to vasopressors4 hours (2 hours before and 2 hours after intervention)Change in urine output measured by FIZE kUO® before and after vasopressor administration
Evaluation of FIZE kUO® Urine Output Monitoring Compared to Manual MeasurementThrough ICU stay, up to 5 daysComparison of FIZE kUO® urine output with manual measurement of urine output

Countries

Israel

Contacts

CONTACTRinat Kalaora
rinat.kalaora@fizemedcial.com+972-544-750887

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 3, 2026